Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)

1 Dec 2017

Abstract excerpt

DNA methylation has been implicated as a promising biomarker for precise cancer diagnosis. However, limited DNA methylation-based biomarkers have been described in esophageal squamous cell carcinoma (ESCC). A high-throughput DNA methylation dataset (100 samples) of ESCC from The Cancer Genome Atlas (TCGA) project was analyzed and validated along with another independent dataset (12 samples) from the Gene...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Epigenetics and DNA Methylation
Share to Esophageal Cancer Research and Treatment
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 29270239
DOI: 10.1186/s13148-017-0430-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 22 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Targeted bisulfite sequencing identified a panel of DNA methylation-based biomarkers for esophageal squamous cell carcinoma (ESCC)PMID 29270239Read ↗

Identification of Hyper-Methylated Tumor Suppressor Genes-Based Diagnostic Panel for Esophageal Squamous Cell Carcinoma (ESCC) in a Chinese Han PopulationSemantic proximity Read ↗

Genome-wide methylation profiling identified methylated KCNA3 and OTOP2 as promising diagnostic markers for esophageal squamous cell carcinomaSemantic proximity Read ↗

Multi-omic characterization of genome-wide abnormal DNA methylation reveals diagnostic and prognostic markers for esophageal squamous-cell carcinomaSemantic proximity Read ↗

Specific DNA methylation markers in the diagnosis and prognosis of esophageal cancerSemantic proximity Read ↗

Identification of DNA methylation-driven genes in esophageal squamous cell carcinoma: a study based on The Cancer Genome AtlasSemantic proximity Read ↗

Aberrant DNA Methylation in Esophageal Squamous Cell Carcinoma: Biological and Clinical ImplicationsSemantic proximity Read ↗

Development and validation of epigenetic signature predict survival for patients with laryngeal squamous cell carcinomaSemantic proximity Read ↗

Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancerSemantic proximity Read ↗

Prognostic CpG Methylation Biomarkers Identified by Methylation Array in Esophageal Squamous Cell Carcinoma PatientsSemantic proximity Read ↗

Identification of key genes by integrating DNA methylation and next-generation transcriptome sequencing for esophageal squamous cell carcinomaSemantic proximity Read ↗

Identification of a DNA methylome signature of esophageal squamous cell carcinoma and potential epigenetic biomarkersSemantic proximity Read ↗

Unlocking Esophageal Carcinoma’s Secrets: An integrated Omics Approach Unveils DNA Methylation as a pivotal Early Detection Biomarker with Clinical ImplicationsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.